23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
The National Labor Relations Board issued a new rule on Friday that will significantly amend NLRB el...
Read More >
In its May 2019 opinion in Vazquez v. Jan-Pro Franchising Int’l, Inc., the Ninth Circuit held that ...
Read More >
As employers prepare plans to handle possible alternate employee work arrangements in light of the 2...
Read More >
In the SBA Procedural Notice dated October 2, 2020 (the “Approval Notice”), the Small Business Adm...
Read More >
On Monday, August 17, 2020, Baker Donelson's Clinton Sanko sat down with Wendell Jisa, CEO of Reveal...
Read More >
Welcome to Episode 8 of Compliance Man Chooses the Target with Tim Khasanov-Batirov. The goal is to ...
Read More >